This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Cardiovascular
Cardiovascular
Blood-thinning drug “avoids stroke”
Firm develops “more-improved” stent
Pill “cuts risk of heart attacks”
Study could improve stroke regimen
Merck “could face 500 Vioxx claims”
Drug’s heart risks “known to maker”
Stem cell trial given go-ahead
Heart pill approved for marketing
St Jude medical announces IRASE AF clinical trial
Ablation “better than heart drugs”
Lercanidipine Actavis launched on day one in major European markets
Weight-loss pill “causes strokes”
« Previous
1
…
43
44
45
46
47
…
72
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: